{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:03:37Z","timestamp":1795017817869,"version":"4.10.1"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100017389","name":"Vasculitis Clinical Research Consortium","doi-asserted-by":"publisher","award":["U54 AR057319"],"award-info":[{"award-number":["U54 AR057319"]}],"id":[{"id":"10.13039\/100017389","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016650","name":"Rare Diseases Clinical Research Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016650","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Office of Rare Diseases Research"},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Science","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["U54 RR019497"],"award-info":[{"award-number":["U54 RR019497"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>ANCA-associated vasculitis (AAV) is a group of multisystem diseases that can have several ocular manifestations. There are published data on ocular manifestations of granulomatosis with polyangiitis (GPA), but few for eosinophilic granulomatosis with polyangiitis (EGPA) or microscopic polyangiitis (MPA). There is little information concerning chronicity, complications, and association with other cranial manifestations of AAV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study retrospectively analysed longitudinal multicentre cohorts of individuals with AAV followed between 2006 and 2022. Data included diagnosis, demographics, cranial manifestations of disease, presence of manifestations at onset of disease and\/or follow-up, and ocular complications of disease. Univariate and multivariable logistic regression analysis assessed associations across disease manifestations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Data from 1441 patients were analysed, including 395 with EGPA, 876 with GPA, and 170 with MPA. Ocular manifestations were seen within 23.1% of patients: 39 (9.9%) with EGPA, 287 (32.7%) with GPA, and 12 (7.1%) with MPA at any time in the disease course. There were more ocular manifestations at onset (n\u2009=\u2009224) than during follow-up (n\u2009=\u2009120). The most common disease-related manifestations were conjunctivitis\/episcleritis and scleritis. In multivariable analysis, dacryocystitis, lacrimal duct obstruction, and retro-orbital disease were associated with sinonasal manifestations of GPA; ocular manifestations were associated with hearing loss in MPA. The most common ocular complications and\/or damage seen were cataracts (n\u2009=\u2009168) and visual impairment (n\u2009=\u2009195).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Ocular manifestations occur in all forms of AAV, especially in GPA. Clinicians should be mindful of the wide spectrum of ocular disease in AAV, caused by active vasculitis, disease-associated damage, and toxicities of therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac663","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T17:11:15Z","timestamp":1669223475000},"page":"2517-2524","source":"Crossref","is-referenced-by-count":45,"title":["Ocular manifestations of ANCA-associated vasculitis"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8416-3955","authenticated-orcid":false,"given":"Mats L","family":"Junek","sequence":"first","affiliation":[{"name":"Division of Rheumatology, St. Joseph\u2019s Healthcare, McMaster University , Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Zhao","sequence":"additional","affiliation":[{"name":"Division of Ophthalmology, St. Joseph\u2019s Healthcare, McMaster University , Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Garner","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, St. Joseph\u2019s Healthcare, McMaster University , Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cuthbertson","sequence":"additional","affiliation":[{"name":"University of South Florida , Tampa, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6287-9549","authenticated-orcid":false,"given":"Christian","family":"Pagnoux","sequence":"additional","affiliation":[{"name":"Mount Sinai Hospital , Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curry L","family":"Koening","sequence":"additional","affiliation":[{"name":"University of Utah , Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A","family":"Langford","sequence":"additional","affiliation":[{"name":"Cleveland Clinic , Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A","family":"McAlear","sequence":"additional","affiliation":[{"name":"University of Pennsylvania , Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A","family":"Monach","sequence":"additional","affiliation":[{"name":"Rheumatology Section, Veteran\u2019s Affairs Boston Healthcare System , Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry W","family":"Moreland","sequence":"additional","affiliation":[{"name":"University of Pittsburgh , Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rennie L","family":"Rhee","sequence":"additional","affiliation":[{"name":"University of Pennsylvania , Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Seo","sequence":"additional","affiliation":[{"name":"Johns Hopkins University , Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Specks","sequence":"additional","affiliation":[{"name":"Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine G","family":"Sreih","sequence":"additional","affiliation":[{"name":"University of Pennsylvania , Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7708-2487","authenticated-orcid":false,"given":"Kenneth","family":"Warrington","sequence":"additional","affiliation":[{"name":"Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E","family":"Wechsler","sequence":"additional","affiliation":[{"name":"National Jewish Health , Denver, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A","family":"Merkel","sequence":"additional","affiliation":[{"name":"University of Pennsylvania , Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader A","family":"Khalidi","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, St. Joseph\u2019s Healthcare, McMaster University , Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,11,28]]},"reference":[{"key":"2023070511445618300_keac663-B1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","article-title":"ANCA-associated vasculitis","volume":"6","author":"Kitching","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2023070511445618300_keac663-B2","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/art.41773","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody\u2013associated vasculitis","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2023070511445618300_keac663-B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2023070511445618300_keac663-B4","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0161-6420(97)30251-6","article-title":"The clinical and pathologic constellation of Wegener granulomatosis of the orbit","volume":"104","author":"Perry","year":"1997","journal-title":"Ophthalmology"},{"key":"2023070511445618300_keac663-B5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0002-9394(76)90784-4","article-title":"Ocular manifestations of Wegener\u2019s granulomatosis","volume":"44","author":"Straatsma BR","year":"1957","journal-title":"Am J Ophthalmol"},{"key":"2023070511445618300_keac663-B6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5582\/irdr.2016.01014","article-title":"Granulomatosis with polyangiitis (Wegener\u2019s disease): an updated review of ocular disease manifestations","volume":"5","author":"Kubaisi","year":"2016","journal-title":"Intractable Rare Dis Res"},{"key":"2023070511445618300_keac663-B7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.semarthrit.2012.08.003","article-title":"Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: a retrospective study of 1286 patients and review of the literature","volume":"42","author":"Rothschild","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"2023070511445618300_keac663-B8","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/rheumatology\/kex261","article-title":"Clinical characteristics of inflammatory ocular disease in anti-neutrophil cytoplasmic antibody associated vasculitis: a retrospective cohort study","volume":"56","author":"Ungprasert","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2023070511445618300_keac663-B9","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum"},{"key":"2023070511445618300_keac663-B10","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780330806","article-title":"The American College of Rheumatology 1990 criteria for the classification of Churg\u2013Strauss syndrome (allergic granulomatosis and angiitis)","volume":"33","author":"Masi","year":"1990","journal-title":"Arthritis Rheum"},{"key":"2023070511445618300_keac663-B11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"2023070511445618300_keac663-B12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/art.1780400222","article-title":"Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides","volume":"40","author":"Exley","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2023070511445618300_keac663-B13","first-page":"1157","article-title":"Damage in ANCA-associated vasculitis: preliminary evidence for the ANCA-associated vasculitis index of damage (AVID)","volume":"54","author":"Seo","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2023070511445618300_keac663-B14","author":"SAS Institute Inc","year":"2021"},{"key":"2023070511445618300_keac663-B15","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/EDE.0b013e3181577511","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE)","volume":"18","author":"Vandenbroucke","year":"2007","journal-title":"Epidemiology"},{"key":"2023070511445618300_keac663-B16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3899\/jrheum.190768","article-title":"Ocular manifestations in rheumatoid arthritis, connective tissue disease, and vasculitis: a systematic review and metaanalysis","volume":"48","author":"Turk","year":"2021","journal-title":"J Rheumatol"},{"key":"2023070511445618300_keac663-B17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00296-019-04242-7","article-title":"Clinical significance of ocular manifestations in granulomatosis with polyangiitis: association with sinonasal involvement and damage","volume":"39","author":"Hinojosa-Azaola","year":"2019","journal-title":"Rheumatol Int"},{"key":"2023070511445618300_keac663-B18","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.rdc.2010.05.005","article-title":"Ocular manifestations of ANCA-associated vasculitis","volume":"36","author":"Kubal","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"key":"2023070511445618300_keac663-B19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/IOP.0000000000001202","article-title":"Ophthalmic eosinophilic granulomatosis with polyangiitis (Churg\u2013Strauss Syndrome): a systematic review of the literature","volume":"35","author":"Akella","year":"2019","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"2023070511445618300_keac663-B20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10384-006-0408-z","article-title":"Eye manifestations in patients with perinuclear antineutrophil cytoplasmic antibody\u2013associated vasculitis: case series and literature review","volume":"51","author":"Matsuo","year":"2007","journal-title":"Jpn J Ophthalmol"},{"key":"2023070511445618300_keac663-B21","first-page":"1025","article-title":"Wegener\u2019s granulomatosis: the relationship between ocular and systemic disease","volume":"28","author":"Harper","year":"2001","journal-title":"J Rheumatol"},{"key":"2023070511445618300_keac663-B22","doi-asserted-by":"crossref","first-page":"iii74","DOI":"10.1093\/rheumatology\/kez618","article-title":"Complications of therapy for ANCA-associated vasculitis","volume":"59","author":"Smith","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2023070511445618300_keac663-B23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/rheumatology\/keu366","article-title":"Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody\u2013associated vasculitides: long-term data from the European Vasculitis Study Group trials","volume":"54","author":"Robson","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"2023070511445618300_keac663-B24","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1056\/NEJMoa1803537","article-title":"Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis","volume":"382","author":"Walsh","year":"2020","journal-title":"New Engl J Med"},{"key":"2023070511445618300_keac663-B25","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the treatment of ANCA-associated vasculitis","volume":"384","author":"Jayne","year":"2021","journal-title":"New Engl J Med"},{"key":"2023070511445618300_keac663-B26","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1001\/jama.2021.6615","article-title":"Effect of reduced-dose vs high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: a randomized clinical trial","volume":"325","author":"Furuta","year":"2021","journal-title":"JAMA"},{"key":"2023070511445618300_keac663-B27","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1093\/rheumatology\/kez071","article-title":"Orbital mass in ANCA-associated vasculitides: data on clinical, biological, radiological and histological presentation, therapeutic management, and outcome from 59 patients","volume":"58","author":"Durel","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2023070511445618300_keac663-B28","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s00417-015-3198-5","article-title":"Rituximab in the treatment of refractory scleritis in patients with granulomatosis with polyangiitis (Wegener\u2019s)","volume":"253","author":"Recillas-Gispert","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac663\/47768639\/keac663.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/7\/2517\/50821660\/keac663.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/7\/2517\/50821660\/keac663.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T13:11:42Z","timestamp":1688562702000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/7\/2517\/6849505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,28]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,11,28]]},"published-print":{"date-parts":[[2023,7,5]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac663","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,7,1]]},"published":{"date-parts":[[2022,11,28]]}}}